Thoracic Surgery Tumor Board Conference (MSH):Malignancies Tumor Board - 3/18/2026

Wednesday, March 18, 2026, 7:30 AM - 8:30 AM, New York, NY


The Thoracic Tumor Board is a specialized, multidisciplinary meeting focused on evaluating and strategizing the treatment plans for patients with cancers affecting the chest cavity, including lung, esophageal, thymic, and pleural cancers. The tumor board brings together a diverse group of medical experts and other healthcare professionals to collaboratively analyze patient cases and formulate the most appropriate and personalized course of treatment.

1. Present Complex patient cases
2. Assessing, diagnosing, and staging different types of cancer

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. 

Date	Empty Column	Title
3/18/2026 7:30:00 AM	Thoracic Surgery Tumor Board Conference (MSH):Malignancies Tumor Board - 3/18/2026 3/18/2026 7:30:00 AM 3/18/2026 8:30:00 AM 15 False MM/DD/YYYY	Thoracic Surgery Tumor Board Conference (MSH):Malignancies Tumor Board - 3/18/2026 The Thoracic Tumor Board is a specialized, multidisciplinary meeting focused on evaluating and strategizing the treatment plans for patients with cancers affecting the chest cavity, including lung, esophageal, thymic, and pleural cancers. The tumor board brings together a diverse group of medical experts and other healthcare professionals to collaboratively analyze patient cases and formulate the most appropriate and personalized course of treatment. Specialties: Diagnostic Radiology, Hematology, Oncology, Pathology, Physician Assistant, Physician Associates/Physician Assistants, Radiation Oncology, Radiology, Thoracic Surgery